Basic Information
RNALocate ID: | RLID:01001398 |
RNA Symbol: | hsa-miR-92a-3p |
Localization: | Cytoplasm |
RNA Information
RNA Name: | hsa-miR-92 |
RNA ID: | miRBase:MIMAT0000092 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 20498841 |
Tissue/Cell Line: | Nasopharyngeal carcinoma cells |
Method: | Next-generation RNA sequencing |
Description: | The expression level of all microRNAs that detected in the nuclear and cytoplasmic 18-30nt sRNA of 293T cell line. Table S5. The N/C values of all isomiRs. The isomiRs are shown only if it displayed a raw read count (non-normalized) more than 10 in at least one library. Data are collected from Table S5, S9. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001399 | Cytoplasm | Cell line (HeLa) | 21695135 |
RLID:01001400 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001401 | Mitochondrion | Myotube | 27396686 |
RLID:01001402 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001403 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001404 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001405 | Nucleolus | Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001406 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:11000937 | Exosome | Human cervical carcinoma cell line (HeLa|SiHa) | 25760330 |
RLID:11000938 | Exosome | Bronchoalveolar lavage fluid|Pooled sera | 27278097 |
RLID:11000939 | Exosome | Glioblastoma cells | 19011622 |
RLID:11000940 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11000941 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11000942 | Exosome | Renal cancer cells | 21670082 |
RLID:11000943 | Exosome | Brain tissue | 23382797 |
RLID:11000944 | Exosome | Plasma | 23663360 |
RLID:11000945 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11000946 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
RLID:11000947 | Extracellular Vesicle | Liposarcoma cell lines (Lipo224B|Lipo246|Lipo863|LPS141)|Preadipocytes | 28588009 |
RLID:11000948 | Microvesicle | Glioblastoma cells | 19011622 |
RLID:11000949 | Microvesicle | Plasma | 23077538 |
RLID:11000950 | Microvesicle | Seminal plasma | 23539611 |
RLID:11000951 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000027 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000291 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-92a-3p | Splenic marginal zone lymphoma | MNDR-E-MI-71170 |
MNDR | hsa-miR-92a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-71171 |
MNDR | hsa-miR-92a-3p | Oral squamous cell carcinoma | MNDR-E-MI-71172 |
MNDR | hsa-miR-92a-3p | Large cell neuroendocrine cancer | MNDR-E-MI-71173 |
MNDR | hsa-miR-92a-3p | Medulloblastoma | MNDR-E-MI-71174 |
MNDR | hsa-miR-92a-3p | B cell lymphoma of malt type | MNDR-E-MI-71175 |
MNDR | hsa-miR-92a-3p | Small intestinal neuroendocrine tumor | MNDR-E-MI-71176 |
MNDR | hsa-miR-92a-3p | Ovarian clear cell carcinoma | MNDR-E-MI-71177 |
MNDR | hsa-miR-92a-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-71178 |
MNDR | hsa-miR-92a-3p | Autism spectrum disorder | MNDR-E-MI-71179 |
MNDR | hsa-miR-92a-3p | Lymphoma | MNDR-E-MI-71180 |
MNDR | hsa-miR-92a-3p | Lymphoma non-hodgkin | MNDR-E-MI-71181 |
MNDR | hsa-miR-92a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-71182 |
MNDR | hsa-miR-92a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-71183 |
MNDR | hsa-miR-92a-3p | Breast cancer luminal | MNDR-E-MI-71184 |
MNDR | hsa-miR-92a-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-71185 |
MNDR | hsa-miR-92a-3p | Dermatomyositis | MNDR-E-MI-71186 |
MNDR | hsa-miR-92a-3p | Prostate cancer | MNDR-E-MI-71187 |
MNDR | hsa-miR-92a-3p | Chronic lymphocytic leukemia | MNDR-E-MI-71188 |
MNDR | hsa-miR-92a-3p | Gastric cancer | MNDR-E-MI-71189 |
MNDR | hsa-miR-92a-3p | Gastric lymphoma | MNDR-E-MI-71190 |
MNDR | hsa-miR-92a-3p | Alzheimer disease | MNDR-E-MI-71191 |
MNDR | hsa-miR-92a-3p | Essential hypertension | MNDR-E-MI-71192 |
MNDR | hsa-miR-92a-3p | Intracranial aneurysm | MNDR-E-MI-71193 |
MNDR | hsa-miR-92a-3p | Esophageal carcinoma | MNDR-E-MI-71194 |
MNDR | hsa-miR-92a-3p | Dysautonomia familial | MNDR-E-MI-71195 |
MNDR | hsa-miR-92a-3p | Duchenne muscular dystrophy | MNDR-E-MI-71196 |
MNDR | hsa-miR-92a-3p | Primary biliary cirrhosis | MNDR-E-MI-71197 |
MNDR | hsa-miR-92a-3p | Malaria | MNDR-E-MI-71198 |
MNDR | hsa-miR-92a-3p | Leukemia | MNDR-E-MI-71199 |
MNDR | hsa-miR-92a-3p | Huntington disease | MNDR-E-MI-71200 |
MNDR | hsa-miR-92a-3p | Chorea | MNDR-E-MI-71201 |
MNDR | hsa-miR-92a-3p | Cardiovascular disease | MNDR-E-MI-71202 |
MNDR | hsa-miR-92a-3p | Carotid stenosis | MNDR-E-MI-71203 |
MNDR | hsa-miR-92a-3p | Moyamoya disease | MNDR-E-MI-71204 |
MNDR | hsa-miR-92a-3p | Lung cancer | MNDR-E-MI-71205 |
MNDR | hsa-miR-92a-3p | Kawasaki disease | MNDR-E-MI-71206 |
MNDR | hsa-miR-92a-3p | Biliary atresia | MNDR-E-MI-71207 |
MNDR | hsa-miR-92a-3p | Down syndrome | MNDR-E-MI-71208 |
MNDR | hsa-miR-92a-3p | Parkinson disease | MNDR-E-MI-71209 |
MNDR | hsa-miR-92a-3p | Breast cancer | MNDR-E-MI-71210 |
MNDR | hsa-miR-92a-3p | Thyroid cancer | MNDR-E-MI-71211 |
MNDR | hsa-miR-92a-3p | Pituitary neoplasms | MNDR-E-MI-71212 |
MNDR | hsa-miR-92a-3p | Pancreatic cancer | MNDR-E-MI-71213 |
MNDR | hsa-miR-92a-3p | Melanoma | MNDR-E-MI-71214 |
MNDR | hsa-miR-92a-3p | Lesch-nyhan syndrome | MNDR-E-MI-71215 |
MNDR | hsa-miR-92a-3p | Rectum adenocarcinoma | MNDR-E-MI-71216 |
MNDR | hsa-miR-92a-3p | Nephroblastoma | MNDR-E-MI-71217 |
MNDR | hsa-miR-92a-3p | Colon cancer | MNDR-E-MI-71218 |
MNDR | hsa-miR-92a-3p | Ischemic attack transient | MNDR-E-MI-71219 |
MNDR | hsa-miR-92a-3p | Colon adenocarcinoma | MNDR-E-MI-71220 |
MNDR | hsa-miR-92a-3p | Multiple sclerosis | MNDR-E-MI-71221 |
MNDR | hsa-miR-92a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-71222 |
MNDR | hsa-miR-92a-3p | Ovarian cancer | MNDR-E-MI-71223 |
MNDR | hsa-miR-92a-3p | Prostate adenocarcinoma | MNDR-E-MI-71224 |
MNDR | hsa-miR-92a-3p | Kidney cancer | MNDR-E-MI-71225 |
MNDR | hsa-miR-92a-3p | Carcinoma ductal breast | MNDR-E-MI-71226 |
MNDR | hsa-miR-92a-3p | Invasive ductal carcinoma | MNDR-E-MI-71227 |
MNDR | hsa-miR-92a-3p | Glioblastoma | MNDR-E-MI-71228 |
MNDR | hsa-miR-92a-3p | Glioma | MNDR-E-MI-71229 |
MNDR | hsa-miR-92a-3p | Nemaline myopathy | MNDR-E-MI-71230 |
MNDR | hsa-miR-92a-3p | Neurilemmoma | MNDR-E-MI-71231 |
MNDR | hsa-miR-92a-3p | Central nervous system lymphoma | MNDR-E-MI-71232 |
MNDR | hsa-miR-92a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-71233 |
MNDR | hsa-miR-92a-3p | Epilepsy temporal lobe | MNDR-E-MI-71234 |
MNDR | hsa-miR-92a-3p | Osteosarcoma | MNDR-E-MI-71235 |
MNDR | hsa-miR-92a-3p | Liposarcoma | MNDR-E-MI-71236 |
MNDR | hsa-miR-92a-3p | Coronary artery disease | MNDR-E-MI-71237 |
MNDR | hsa-miR-92a-3p | Inclusion body myositis | MNDR-E-MI-71238 |
MNDR | hsa-miR-92a-3p | Infarction middle cerebral artery | MNDR-E-MI-71239 |
MNDR | hsa-miR-92a-3p | Liver cancer | MNDR-E-MI-71240 |
MNDR | hsa-miR-92a-3p | Cervical adenocarcinoma | MNDR-E-MI-71241 |
MNDR | hsa-miR-92a-3p | Gastric adenocarcinoma | MNDR-E-MI-71242 |
MNDR | hsa-miR-92a-3p | Cervical squamous cell carcinoma | MNDR-E-MI-71243 |
MNDR | hsa-miR-92a-3p | Pituitary adenoma | MNDR-E-MI-71244 |
MNDR | hsa-miR-92a-3p | Lung squamous cell carcinoma | MNDR-E-MI-71245 |
MNDR | hsa-miR-92a-3p | Thyroid carcinoma | MNDR-E-MI-71246 |
MNDR | hsa-miR-92a-3p | Bladder urothelial carcinoma | MNDR-E-MI-71247 |
MNDR | hsa-miR-92a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-71248 |
MNDR | hsa-miR-92a-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-71249 |
MNDR | hsa-miR-92a-3p | Carcinoma renal cell | MNDR-E-MI-71250 |
MNDR | hsa-miR-92a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-71251 |
MNDR | hsa-miR-92a-3p | Renal clear cell carcinoma | MNDR-E-MI-71252 |
MNDR | hsa-miR-92a-3p | Esophageal cancer | MNDR-E-MI-71253 |
MNDR | hsa-miR-92a-3p | Liver cirrhosis | MNDR-E-MI-71254 |
MNDR | hsa-miR-92a-3p | Prolactinoma | MNDR-E-MI-71255 |
MNDR | hsa-miR-92a-3p | Lung small cell carcinoma | MNDR-E-MI-71256 |
MNDR | hsa-miR-92a-3p | Schizophrenia | MNDR-E-MI-71257 |
MNDR | hsa-miR-92a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-71258 |
MNDR | hsa-miR-92a-3p | Heart failure | MNDR-E-MI-71259 |
MNDR | hsa-miR-92a-3p | Fibromyalgia | MNDR-E-MI-71260 |
MNDR | hsa-miR-92a-3p | Encephalomyelitis | MNDR-E-MI-71261 |
MNDR | hsa-miR-92a-3p | Breast invasive carcinoma | MNDR-E-MI-71262 |
MNDR | hsa-miR-92a-3p | Early hepatocellular carcinoma | MNDR-E-MI-71263 |
MNDR | hsa-miR-92a-3p | B-cell lymphoma | MNDR-E-MI-71264 |
MNDR | hsa-miR-92a-3p | Rheumatoid arthritis | MNDR-E-MI-71265 |
MNDR | hsa-miR-92a-3p | T-cell leukemia | MNDR-E-MI-71266 |
MNDR | hsa-miR-92a-3p | Retinoblastoma | MNDR-E-MI-71267 |
MNDR | hsa-miR-92a-3p | Neuroblastoma | MNDR-E-MI-71268 |
MNDR | hsa-miR-92a-3p | Barrett's adenocarcinoma | MNDR-E-MI-71269 |
MNDR | hsa-miR-92a-3p | Burkitt lymphoma | MNDR-E-MI-71270 |
MNDR | hsa-miR-92a-3p | Lymphosarcoma | MNDR-E-MI-71271 |
MNDR | hsa-miR-92a-3p | Tonsil cancer | MNDR-E-MI-71272 |
MNDR | hsa-miR-92a-3p | Acute myelocytic leukemia | MNDR-E-MI-71273 |
MNDR | hsa-miR-92a-3p | Colorectal cancer | MNDR-E-MI-71274 |
MNDR | hsa-miR-92a-3p | Nasopharynx carcinoma | MNDR-E-MI-71275 |
MNDR | hsa-miR-92a-3p | Multiple myeloma | MNDR-E-MI-71276 |
MNDR | hsa-miR-92a-3p | Acute lymphocytic leukemia | MNDR-E-MI-71277 |
MNDR | hsa-miR-92a-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-71278 |
MNDR | hsa-miR-92a-3p | Ependymoma | MNDR-E-MI-71279 |
MNDR | hsa-miR-92a-3p | Nasopharyngeal cancer | MNDR-E-MI-71280 |
MNDR | hsa-miR-92a-3p | Prostatic neoplasms | MNDR-E-MI-71281 |
MNDR | hsa-miR-92a-3p | Arsenic poisoning | MNDR-E-MI-71282 |
MNDR | hsa-miR-92a-3p | Pelvic organ prolapse | MNDR-E-MI-71283 |
MNDR | hsa-miR-92a-3p | Stroke lacunar | MNDR-E-MI-71284 |
MNDR | hsa-miR-92a-3p | Barrett's carcinogenesis | MNDR-E-MI-71285 |
MNDR | hsa-miR-92a-3p | Duke A | MNDR-E-MI-71286 |
MNDR | hsa-miR-92a-3p | Low grade dysplastic nodule | MNDR-E-MI-71287 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABHD13 | Homo sapiens | RR00025394 |
TOP